Journal News

Proteomic clues to oocyte development

Arti Dumbrepatil
June 7, 2023

In a female germ cell, also known as an oocyte, maturation is orchestrated by such biological processes as chromosome segregation, mRNA decay and metabolic changes. Defects in any one of these processes can lead to infertility, meiotic defects and/or embryonic arrest. Successful oocyte maturation requires interplay between translation and degradation of key proteins involved in germ cell division. To advance reproductive medicine, researchers need to understand the mechanisms from oocyte to mature egg.

To help unravel these mechanisms, a team of researchers led by Hongzheng Sun and Guanyi Sun of the Nanjing Medical University in China carried out proteomic profiling of mouse oocytes at three developmental stages, identifying functions of critical proteins and pathways for maturation. This study was published in the journal Molecular & Cellular Proteomics.

“Simply put, we interpreted the maturation process of mouse oocytes with proteomics and discovered signaling pathways and functional proteins that regulate oocyte maturation,” Hongzheng Sun said. “Our data serves as an important resource on the dynamic biological processes occurring in oocyte proteome and provides knowledge to better understand the molecular mechanisms during female germ cell development.”

Using eggs taken from artificially superovulated mice, the researchers analyzed the oocytes’ maturation with optimized liquid chromatography with tandem mass spectrometry. They identified 4,694 proteins and found that 634 of them changed significantly across multiple developmental stages. The team also studied the functions of critical proteins and metabolic pathways for oocyte maturation. These include increased levels of proteins related to cell cycle regulation, a decline in histone acetylation accompanied by an increase in deacetylases, maternal mRNA decay with upregulation of exoribonucleases, and protein degradation with active ubiquitinoylation in mouse oocytes.

Although the study was conducted in maturing oocytes, it has limitations. “We have used siRNA interference to investigate the function of key proteins and can limit the knockdown efficiency, leading to incomplete elimination of the target protein,” Sun said.

Also, the individual proteins they studied are upregulated mainly during maturation, while proteins with reduced expression important for oocyte development need further characterization.

The researchers are excited about their results and plan to pursue studies in two directions. “Firstly, we want to continue to mine proteins from the current proteomic profiling data set and continue to study their functions in oocyte maturation,” Sun said. “Secondly, we want to collaborate with clinicians to screen for genetic mutations causing infertility in women.”

With such proteomic data sets, researchers can establish screens to detect human oocyte abnormalities. For example, if an abnormally expressed protein blocks oocyte maturation, then researchers can study the defects to determine whether they are caused by specific gene mutations.

This study not only has helped to advance knowledge of oocyte development but also has affected the lead researcher’s personal health goals.

“While studying reproduction biology we observed that obesity negatively impacts male and female reproduction systems,” Sun said. “When I learned about this, I started running to maintain a healthy weight. My research made me realize the importance of good health.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Arti Dumbrepatil

Arti Dumbrepatil is a freelance science writer and communicator. With her academic training plus expertise in science communication and writing, she demystifies and transforms complex, jargon-filled science into enjoyable and comprehensible content that resonates with a diverse audience. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

How Alixorexton could transform narcolepsy treatment
News

How Alixorexton could transform narcolepsy treatment

Nov. 18, 2025

A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Profile

Phosphatases and pupils: A dual legacy

Nov. 13, 2025

Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Journal News

Extracellular vesicles offer clues to cattle reproduction

Nov. 11, 2025

Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Journal News

Proteomics reveals protein shifts in diabetic eye disease

Nov. 11, 2025

Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.